Fresenius Medical Care (NYSE:FMS) Sees Large Volume Increase – Time to Buy?

Shares of Fresenius Medical Care AG (NYSE:FMS) saw strong trading volume on Wednesday . 740,733 shares traded hands during mid-day trading, an increase of 138% from the previous session’s volume of 310,951 shares.The stock last traded at $24.66 and had previously closed at $24.47.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Truist Financial raised their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a report on Monday, December 2nd.

Fresenius Medical Care Price Performance

The company has a market capitalization of $14.53 billion, a price-to-earnings ratio of 20.48, a price-to-earnings-growth ratio of 0.76 and a beta of 0.99. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The business has a fifty day moving average price of $23.73 and a 200 day moving average price of $22.28.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Millennium Management LLC grew its holdings in Fresenius Medical Care by 5,297.5% during the fourth quarter. Millennium Management LLC now owns 722,238 shares of the company’s stock worth $16,351,000 after acquiring an additional 708,857 shares during the period. Integral Health Asset Management LLC grew its holdings in Fresenius Medical Care by 33.3% during the fourth quarter. Integral Health Asset Management LLC now owns 600,000 shares of the company’s stock worth $13,584,000 after acquiring an additional 150,000 shares during the period. Northern Trust Corp grew its holdings in Fresenius Medical Care by 45.9% during the fourth quarter. Northern Trust Corp now owns 362,190 shares of the company’s stock worth $8,200,000 after acquiring an additional 113,953 shares during the period. Moran Wealth Management LLC grew its holdings in Fresenius Medical Care by 9.1% during the fourth quarter. Moran Wealth Management LLC now owns 254,710 shares of the company’s stock worth $5,767,000 after acquiring an additional 21,334 shares during the period. Finally, ABC Arbitrage SA acquired a new position in Fresenius Medical Care during the fourth quarter worth about $4,215,000. 8.37% of the stock is owned by institutional investors and hedge funds.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.